Katsumi Higaki Selected Research

GM1 Gangliosidosis (Gangliosidosis GM1)

11/2020	Morquio B Disease. Disease Characteristics and Treatment Options of a Distinct GLB1-Related Dysostosis Multiplex.
5/2014	Structural basis of pharmacological chaperoning for human β-galactosidase.
3/2013	A bicyclic 1-deoxygalactonojirimycin derivative as a novel pharmacological chaperone for GM1 gangliosidosis.
8/2011	Lysosomal accumulation of Trk protein in brain of GM₁ -gangliosidosis mouse and its restoration by chemical chaperone.
11/2009	Intracerebral cell transplantation therapy for murine GM1 gangliosidosis.
9/2006	Fibroblast screening for chaperone therapy in beta-galactosidosis.
12/2003	Chemical chaperone therapy for brain pathology in G(M1)-gangliosidosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katsumi Higaki Research Topics

Disease

14	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 04/2022 - 06/2004
12	Gaucher Disease (Gaucher's Disease) 01/2019 - 08/2004
8	Lysosomal Storage Diseases (Lysosomal Storage Disease) 03/2019 - 12/2003
7	GM1 Gangliosidosis (Gangliosidosis GM1) 11/2020 - 12/2003
6	Mucopolysaccharidosis IV (Morquio Syndrome) 01/2017 - 12/2003
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 02/2004
4	Graves Disease (Basedow Disease) 06/2019 - 05/2014
3	Long QT Syndrome 10/2016 - 02/2011
3	Neurologic Manifestations (Neurological Manifestations) 03/2016 - 09/2007
3	Neoplasms (Cancer) 09/2011 - 05/2007
2	Disease Progression 01/2020 - 01/2017
2	Long Qt Syndrome 2 11/2016 - 12/2013
2	Neuraminidase deficiency with beta-galactosidase deficiency 02/2016 - 10/2008
2	Fabry Disease (Fabry's Disease) 09/2015 - 07/2014
2	Hyperthyroidism 01/2015 - 05/2014
2	Sphingolipidoses (Sphingolipidosis) 04/2013 - 08/2004
2	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 11/2011 - 12/2008
2	Mucolipidoses (Sialidosis) 10/2011 - 12/2009
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 02/2010 - 02/2009
2	Tuberous Sclerosis (Bourneville's Disease) 09/2007 - 05/2007
2	Neuroblastoma 02/2007 - 11/2005
1	Tay-Sachs Disease 12/2022
1	Atrial Remodeling 07/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 04/2022
1	Melanoma (Melanoma, Malignant) 01/2021
1	Ototoxicity 01/2021
1	Pain (Aches) 11/2020
1	Niemann-Pick Diseases (Niemann Pick Disease) 09/2020
1	Hyperuricemia 07/2020
1	Gout 07/2020
1	Infections 01/2020
1	Rare Diseases (Rare Disease) 01/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	COVID-19 01/2020
1	Hepatomegaly 03/2019
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Mannosidase Deficiency Diseases (Mannosidosis) 01/2019
1	Immunoglobulin G4-Related Disease 10/2018
1	Lipidoses 01/2017
1	Body Weight (Weight, Body) 01/2017
1	Weight Loss (Weight Reduction) 01/2017

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 04/2022 - 10/2008
9	Glucosylceramidase (Glucocerebrosidase)IBA 01/2018 - 11/2009
8	CholesterolIBA 04/2022 - 02/2004
7	GalactosidasesIBA 01/2017 - 08/2011
6	EnzymesIBA 12/2022 - 10/2011
5	LipidsIBA 01/2020 - 06/2004
5	CyclodextrinsIBA 01/2017 - 01/2014
5	AcidsIBA 04/2014 - 11/2010
4	Pharmaceutical PreparationsIBA 01/2020 - 04/2013
4	GlucosidasesIBA 04/2014 - 11/2010
3	Uric Acid (Urate)IBA 07/2022 - 08/2015
3	SphingolipidsIBA 01/2020 - 02/2004
3	Long-Acting Thyroid Stimulator (LATS)IBA 10/2018 - 05/2014
3	Ambroxol (Mucosolvan)IBA 03/2016 - 04/2013
3	beta-Galactosidase (Lactaid)IBA 10/2008 - 09/2006
3	N-octyl-beta-valienamineIBA 09/2006 - 12/2003
2	Mutant Proteins (Protein, Mutant)IBA 10/2016 - 09/2013
2	Cathepsin AIBA 02/2016 - 10/2008
2	Neuraminidase (Sialidase)IBA 02/2016 - 10/2008
2	UbiquitinIBA 09/2015 - 12/2008
2	Proteasome Endopeptidase Complex (Proteasome)IBA 09/2015 - 12/2008
2	Phosphotransferases (Kinase)IBA 03/2015 - 10/2011
2	GlycosidesIBA 01/2015 - 08/2012
2	migalastatIBA 07/2014 - 03/2013
2	Carrier Proteins (Binding Protein)IBA 11/2011 - 12/2008
2	Cardiac MyosinsIBA 11/2011 - 12/2008
2	DystrophinIBA 02/2010 - 02/2009
2	trans-sodium crocetinate (crocetin)IBA 09/2007 - 05/2007
2	Tuberous Sclerosis Complex 1 ProteinIBA 09/2007 - 05/2007
1	Hexosaminidase A (Hex A)IBA 12/2022
1	Hexosaminidases (Hexosaminidase)IBA 12/2022
1	InflammasomesIBA 07/2022
1	Hormones (Hormone)IBA 04/2022
1	SteroidsIBA 04/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	IgA receptor (protein B)IBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	CytokinesIBA 11/2020
1	sphingosine phosphorylcholineIBA 09/2020
1	Serine (L-Serine)FDA Link 09/2020
1	Phosphorylcholine (Phosphocholine)IBA 09/2020
1	Estradiol (Delestrogen)FDA LinkGeneric 06/2019
1	alpha-SynucleinIBA 01/2019
1	alpha-Mannosidase (LAMAN)IBA 01/2019
1	MannosidasesIBA 01/2019
1	AntibodiesIBA 10/2018
1	Immunoglobulin G (IgG)IBA 10/2018
1	RNA IIBA 10/2018
1	Epstein-Barr virus encoded RNA 1IBA 10/2018
1	isofagomineIBA 01/2017
1	(5aR)-5a-C-pentyl-4-epi-isofagomineIBA 01/2017
1	Vorinostat FDA Link 01/2017
1	Niemann-Pick C1 ProteinIBA 01/2017
1	Histone Deacetylase InhibitorsIBA 01/2017
1	NucleotidesIBA 01/2017
1	Ether (Diethyl Ether)IBA 11/2016

Therapy/Procedure

13	Therapeutics 11/2020 - 12/2003
1	Enzyme Replacement Therapy 11/2020